Minnesota PFAS Law (Amara's Law)

Minnesota's comprehensive regulatory framework for per- and polyfluoroalkyl substances (PFAS), including reporting requirements, fees, and a phase-out of non-essential uses in products (Statute 116.9407).

Foresight tracks Minnesota PFAS Law (Amara's Law) developments and surfaces the alerts most likely to matter before they turn into missed deadlines, recalls, or escalation work.

Not ready for a trial? Take the 3-minute readiness assessment

Current activity

Cooling

91% below the prior 8-week baseline

3-month trend

Latest alerts below

Last updated

5 May 2026, 14:07

View alerts

Latest Minnesota PFAS Law (Amara's Law) developments

Source-backed regulatory and guidance signals tracked by Foresight, with the newest developments first.

Minnesota Pollution Control Agency Publishes PRISM Training Videos and Reiterates 2026 PFAS Product Reporting Deadlines

In April 2026, the Minnesota Pollution Control Agency released new PRISM training videos and guidance to help manufacturers comply with PFAS in products reporting requirements under Amara’s Law. Companies selling PFAS-containing products into Minnesota should now mobilise data collection and supplier engagement to meet the 16 August 2026 extension deadline, 15 September 2026 initial reporting deadline, and ongoing 1 February annual update obligations while managing PFAS substitution and disclosure risk.

pca.state.mn.usUnited StatesUnited States

Minnesota SF5092 Bill Would Delay PFAS Reporting and Define "Currently Unavoidable Uses" Exemptions

Minnesota’s SF5092 bill would push back the start of manufacturer reporting for products containing intentionally added PFAS to July 2027 and write a broad set of “currently unavoidable use” exemptions into the state’s PFAS product statute. If enacted, this would delay near-term PFAS reporting pressure while locking in long-term carve-outs for vehicles, semiconductors, HVAC, critical infrastructure, and other complex goods, so companies selling into Minnesota will need to reassess which product lines remain covered by the 2032 PFAS product ban and related disclosure obligations.

revisor.mn.govUnited StatesUnited States

Minnesota MPCA Extends PFAS in Products Reporting Deadline to 15 September 2026

Minnesota’s pollution control agency has pushed back the first PFAS-in-products reporting deadline under Amara’s Law to 15 September 2026 and created a streamlined extension and waiver process, giving manufacturers additional time and support to submit PRISM reports. This extension reduces near-term compliance pressure but does not weaken the obligation to map PFAS use across complex product portfolios, and it signals Minnesota’s continued drive toward stricter PFAS controls and the planned phase-out of nonessential PFAS uses by 2032.

pca.state.mn.usUnited StatesUnited States

Minnesota House Introduces HF 4761 on PFAS Exemption for Agricultural Products and Equipment

Minnesota introduced legislation in March 2026 to exempt agricultural products and equipment from the state's comprehensive PFAS restrictions. This proposal signals a potential narrowing of Amara's Law, offering regulatory relief for pesticide, fertilizer, and machinery manufacturers currently facing broad PFAS bans.

house.mn.govUnited StatesUnited States

Minnesota MPCA Reminder: Feedback On PFAS Currently Unavoidable Use Rule Concepts Closes 29 March 2026

Minnesota is finalizing the Currently Unavoidable Use framework for PFAS, with public feedback on core rule concepts closing in late March 2026. This process establishes the essentiality criteria and application deadlines that will determine which products can maintain market access beyond the state's 2032 broad prohibition.

pca.state.mn.usUnited StatesUnited States

Minnesota SF4758 Proposes Exemption For Agricultural Products And Equipment From PFAS Product Rules

Minnesota introduced legislation in March 2026 to exempt agricultural products and farm equipment from the state's comprehensive PFAS reporting and phase-out mandates. This proposal signals a potential shift toward sector-specific carve-outs, which would significantly reduce compliance and substitution pressures for the agricultural and machinery supply chains.

revisor.mn.govUnited StatesUnited States

Minnesota HF 4276 Would Require 2028 Report on Fluoropolymers in Consumer Products

Minnesota HF 4276 mandates a comprehensive 2028 report on the health impacts, regulatory needs, and critical uses of fluoropolymers in consumer products. This initiative establishes the administrative and scientific groundwork for future restrictions or essential use exemptions for fluorinated polymers in the state.

revisor.mn.govUnited StatesUnited States

Minnesota Legislature Introduces HF 4257 to Delay PFAS Product Reporting and Define Unavoidable Uses

Minnesota has introduced legislation to delay PFAS product reporting until July 2027 and codify broad currently unavoidable use exemptions for critical industries. This proposal signals a pragmatic adjustment to the state's PFAS ban, offering significant compliance relief and long-term market access for manufacturers of complex goods and electronics.

revisor.mn.govUnited StatesUnited States

Minnesota MPCA Publishes 2025 PFAS Private Well Sampling Report for East Metro Area

Minnesota's 2025 PFAS sampling report reveals a significant increase in remediation obligations following the adoption of stricter state and federal drinking water standards. This trend signals escalating liability risks for manufacturers as regulators retroactively apply lower toxicity thresholds to trigger mandatory cleanup and long-term water treatment actions.

lrl.mn.govUnited StatesUnited States

Minnesota Bill SF 4362 Proposes Higher Funding For Emerging Contaminants Drinking Water Grants

Minnesota SF 4362 proposes to more than double the state grant cap for drinking water infrastructure projects addressing emerging contaminants like PFAS. This expansion signals an intensified state commitment to remediation that could accelerate utility upgrades and shift significant compliance costs from local operators to state funds.

revisor.mn.govUnited StatesUnited States

Minnesota HF 4002 Proposes Veterinary Product Exemption From PFAS Product Ban

Minnesota proposed legislation in March 2026 to expand PFAS ban exemptions for federally regulated medical, pharmaceutical, and veterinary products. This move signals a strategic shift toward protecting essential healthcare supply chains and could significantly reduce compliance complexity for life sciences manufacturers.

revisor.mn.govUnited StatesUnited States

Minnesota Senate Introduces SF 4207 on Priority PFAS Identification and PFOA/PFOS Water Quality Standards

Minnesota is advancing legislation to mandate water quality standards for PFOA and PFOS and establish a systematic management protocol for priority PFAS by 2028. Businesses should anticipate more stringent effluent limits and expanded monitoring obligations as the state formalizes its regulatory framework for PFAS in industrial and wastewater discharges.

revisor.mn.govUnited StatesUnited States

Minnesota Senate Introduces SF 4277 To Amend PFAS 'Currently Unavoidable Use' Definition In Pesticide Control Chapter

Minnesota introduced legislation to broaden the currently unavoidable use criteria for PFAS in pesticides by incorporating pest resistance and the comparative impacts of alternatives. This shift suggests a more pragmatic approach to PFAS phase-outs in the agricultural sector, potentially providing a pathway for continued use where alternatives are insufficient or riskier.

revisor.mn.govUnited StatesUnited States

Minnesota Legislature Proposes PFAS Biomonitoring Appropriation (HF 3934)

Minnesota is proposing significant funding to expand PFAS biomonitoring in metropolitan areas through 2027. Enhanced data on human exposure levels will likely accelerate state-level regulatory restrictions and increase liability risks for companies with PFAS in their products or supply chains.

revisor.mn.govUnited StatesUnited States

Minnesota Bill SF4173 Proposes PFAS Exemption for Veterinary and Medical Products

Minnesota introduced legislation in March 2026 to expand PFAS ban exemptions for federally regulated medical and veterinary products. This proposal signals a shift toward balancing environmental goals with healthcare continuity, potentially reducing market access risks for life sciences companies.

revisor.mn.govUnited StatesUnited States

Minnesota Legislature Introduces HF 4109 To Broaden PFAS "Currently Unavoidable Use" Definition In Pesticide Control Statute

Minnesota introduced legislation in March 2026 to expand the currently unavoidable use definition for PFAS in pesticide products. Broadening essentiality criteria to include animal health and pest resistance provides a potential regulatory pathway to maintain market access for PFAS-containing formulations.

revisor.mn.govUnited StatesUnited States

Minnesota House Capital Investment Committee Holds PFAS Briefing

Minnesota legislators are intensifying focus on PFAS through high-level briefings on contamination and capital investment needs. This signals potential for expanded state funding for remediation and stricter regulatory oversight, requiring businesses to monitor Minnesota's evolving PFAS policy landscape for operational and liability risks.

Source-backed alertUnited StatesUnited States

Minnesota SF3884 Would Appropriate Funds for East Metro PFAS Biomonitoring

Minnesota introduced legislation in February 2026 to secure funding for continued PFAS biomonitoring in eastern metropolitan communities through 2027. Sustained state investment in exposure data collection will likely provide the evidentiary basis for future litigation and more stringent environmental or product regulations.

revisor.mn.govUnited StatesUnited States

Minnesota MPCA Seeks Feedback on Draft CUU Rule Concepts for PFAS in Products

Minnesota has detailed the proposed Currently Unavoidable Use framework, signaling a 2030 deadline for manufacturers to justify PFAS use before the 2032 market ban. Companies must prioritize rigorous alternatives assessments and technical documentation now to defend product essentiality and maintain long-term market access.

scs-public.s3-us-gov-west-1.amazonaws.comUnited StatesUnited States

Minnesota HF 3637 Proposes PFAS Drinking Water Treatment Design Funding for Oak Park Heights

Minnesota introduced legislation to fund the design of municipal water treatment infrastructure specifically for PFAS remediation. This signals a growing state-level commitment to infrastructure-based mitigation that likely precedes stricter discharge limits and increased liability for upstream PFAS users.

revisor.mn.govUnited StatesUnited States

Related topics

Not a newsletter. Not a feed. Structured intelligence mapped to your business.

These are just a few of the most recent Minnesota PFAS Law (Amara's Law) alerts. Foresight tracks every jurisdiction, every day — and surfaces only what affects your portfolio, with full citations and evidence.

Start free trial

Topic context

How to read Minnesota PFAS Law (Amara's Law) regulatory activity

Definition

What is Minnesota PFAS Law (Amara's Law)?

Minnesota's comprehensive regulatory framework for per- and polyfluoroalkyl substances (PFAS), including reporting requirements, fees, and a phase-out of non-essential uses in products (Statute 116.9407).

Industry relevance

Why it matters

Minnesota PFAS Law (Amara's Law) developments can change product scope, supplier expectations, market access, reporting duties, and risk ownership. Foresight tracks the signals early so teams can respond before obligations become urgent.

Foresight tracking

How Foresight monitors it

Foresight monitors official sources, extracts structured regulatory intelligence, and maps alerts to a customer's products, substances, markets, and priorities so teams see the relevant signal with source evidence for review.

Frequently asked questions

Everything you need to know about Foresight's regulatory intelligence platform

Still have questions? Get in touch with our team

Join 3,500+ professionals staying ahead

Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.

Free forever. Unsubscribe anytime.

Read by professionals at

Boeing
AstraZeneca
Siemens
PepsiCo
SpaceX